Thyagarajan Ramachandran - Healthcare Triangle Chief Officer
| HCTI Stock | USD 0.68 0.15 18.07% |
Insider
Thyagarajan Ramachandran is Chief Officer of Healthcare Triangle
| Age | 48 |
| Address | 7901 Stoneridge Drive, Pleasanton, CA, United States, 94588 |
| Phone | 925 270 4812 |
| Web | https://www.healthcaretriangle.com |
Healthcare Triangle Management Efficiency
The company has return on total asset (ROA) of (0.545) % which means that it has lost $0.545 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8756) %, meaning that it created substantial loss on money invested by shareholders. Healthcare Triangle's management efficiency ratios could be used to measure how well Healthcare Triangle manages its routine affairs as well as how well it operates its assets and liabilities. The Healthcare Triangle's current Return On Tangible Assets is estimated to increase to -1.93. The Healthcare Triangle's current Return On Capital Employed is estimated to increase to -5.6. As of now, Healthcare Triangle's Intangible Assets are increasing as compared to previous years. The Healthcare Triangle's current Non Current Assets Total is estimated to increase to about 7 M, while Total Assets are projected to decrease to under 9.9 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Tan | EUDA Health Holdings | 43 | |
| Steven Sabes | FOXO Technologies | 56 | |
| Anthony Colaluca | MultiPlan | 54 | |
| Paul Emery | MultiPlan | 35 | |
| Jim Grauel | FOXO Technologies | N/A | |
| Susan Mohler | MultiPlan | N/A | |
| Erick Fernandez | CareMax | 45 | |
| Carlos Solo | CareMax | 45 | |
| Pamela Walker | MultiPlan | N/A | |
| Paul Galant | MultiPlan | 52 | |
| Michael Klein | MultiPlan | 57 | |
| Glenn August | MultiPlan | 59 | |
| Brian Chen | FOXO Technologies | N/A | |
| Robert Potashnick | FOXO Technologies | N/A | |
| Kevin Wirges | CareMax | 44 | |
| William Veghte | MultiPlan | 53 | |
| Julie Klapstein | MultiPlan | 66 | |
| Wei Chen | EUDA Health Holdings | 39 | |
| Jeffrey Doctoroff | MultiPlan | 55 | |
| Susan Neo | FOXO Technologies | N/A | |
| P Philbrick | MultiPlan | 41 | |
Management Performance
| Return On Equity | -2.88 | ||||
| Return On Asset | -0.55 |
Healthcare Triangle Leadership Team
Elected by the shareholders, the Healthcare Triangle's board of directors comprises two types of representatives: Healthcare Triangle inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthcare. The board's role is to monitor Healthcare Triangle's management team and ensure that shareholders' interests are well served. Healthcare Triangle's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthcare Triangle's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shibu Kizhakevilayil, Head Director | ||
| Suresh Venkatachari, Pres Chairman | ||
| Lakshmanan Kannappan, Head Director | ||
| Kristi Lane, VP Management | ||
| Sudish Mogli, Consultant | ||
| Thyagarajan Ramachandran, Chief Officer | ||
| Michael Campana, Vice Marketing | ||
| Chris Paalman, Director Operations | ||
| Abhay Borwankar, Vice Technology | ||
| Michael Gill, VP Fin | ||
| Anand Kumar, Interim Officer | ||
| Damian David, Senior Development |
Healthcare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthcare Triangle a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.88 | ||||
| Return On Asset | -0.55 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | (0.46) % | ||||
| Current Valuation | 5.76 M | ||||
| Shares Outstanding | 5.67 M | ||||
| Shares Owned By Insiders | 45.93 % | ||||
| Shares Owned By Institutions | 3.27 % | ||||
| Number Of Shares Shorted | 632.84 K | ||||
| Price To Book | 0.87 X |
Currently Active Assets on Macroaxis
When determining whether Healthcare Triangle offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthcare Triangle's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthcare Triangle Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthcare Triangle Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Healthcare Triangle. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Triangle. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share 4.813 | Quarterly Revenue Growth (0.65) | Return On Assets (0.55) | Return On Equity (2.88) |
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Triangle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.